Streetbeat News

Revenues

BLRX

As of June 30, 2024, BioLineRx had $40.1 million in cash, cash equivalents, and short-term bank deposits, which is expected to be sufficient to fund operations into 2025.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:29 am

CSCO

GOOGL

LITE

NKE

QQQ

SPY

WMT

U.S. stocks are poised for a modestly higher start, with the S&P 500 aiming for a sixth consecutive win. Key data on job market, consumer spending, and manufacturing activity, along with retail earnings, will influence trading. Walmart's strong earnings and guidance boost shares, while Alphabet faces potential DOJ action. Cisco and Lumentum see premarket gains on positive earnings. Upcoming economic data and Fed speeches will be closely watched.

Portfolio Pulse from Shanthi Rexaline

August 15, 2024 | 11:29 am

CLBT

Cellebrite has increased its 2024 revenue outlook from $370M-$380M to $390M-$398M, surpassing the estimated $378.306M. The company also projects Q3 revenue of $100M-$104M, exceeding the estimated $94.77M.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:26 am

HPH

MKTW

RILY

The article highlights three oversold financial stocks with potential for recovery: Highest Performances Holdings Inc (HPH), B Riley Financial Inc (RILY), and MarketWise Inc (MKTW). These stocks have experienced significant price declines and have RSI values indicating they are oversold.

Portfolio Pulse from Avi Kapoor

August 15, 2024 | 11:22 am

TRAW

Traws Pharma (NASDAQ:TRAW) reported a Q2 2024 GAAP EPS loss of $(4.87) per share and sales of $57.00K, a 5% decrease from $60.00K YoY.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:19 am

SLSR

Solaris Resources has reported drill results from its ongoing 60,000-meter and 8-rig drilling program at its Warintza Project in southeastern Ecuador.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:18 am

DEC

Diversified Energy Company reported a net income of $16M for the six months ended June 30, inclusive of $98M in tax benefits, and an adjusted EBITDA of $218M. The company maintained flat production volumes since 4Q2023, with a June 2024 exit rate of 855 MMcfepd, including the impact of the Oaktree Acquisition.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:14 am

GAMB

Gambling.com Group has updated its 2024 full-year revenue and Adjusted EBITDA guidance. The company now expects revenue of $123M-$127M and Adjusted EBITDA of $44M-$47M, reflecting year-over-year growth of 15% and 24%, respectively. This is an increase from the previous guidance of $118M-$122M for revenue and $40M-$44M for Adjusted EBITDA.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:11 am

EXAS

Exact Sciences shared new modeling data on the projected impact of the Cologuard test on patients, health care professionals, and the U.S. health care system since its FDA approval 10 years ago.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:10 am

SPTN

SpartanNash has reaffirmed its FY24 guidance, projecting total net sales between $9.50 billion and $9.70 billion, with an estimated midpoint of $9.60 billion. The company also expects adjusted EPS to range from $1.85 to $2.10, with an estimated midpoint of $2.02.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2024 | 11:09 am